These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32436932)

  • 21. miRNAs and cancer: an epigenetics view.
    Malumbres M
    Mol Aspects Med; 2013; 34(4):863-74. PubMed ID: 22771542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective activation of miRNAs of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem cells and possible contribution to regulation of apoptosis.
    Nguyen PN; Huang CJ; Sugii S; Cheong SK; Choo KB
    J Biomed Sci; 2017 Mar; 24(1):20. PubMed ID: 28270145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer.
    Ma MZ; Li CX; Zhang Y; Weng MZ; Zhang MD; Qin YY; Gong W; Quan ZW
    Mol Cancer; 2014 Jun; 13():156. PubMed ID: 24953832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring microRNA Regulation of Cancer with Context-Aware Deep Cancer Classifier.
    Pyman B; Sedghi A; Azizi S; Tyryshkin K; Renwick N; Mousavi P
    Pac Symp Biocomput; 2019; 24():160-171. PubMed ID: 30864319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of heterogeneous genetic variations of microRNA regulome in cancer.
    Hrovatin K; Kunej T
    Cancer Lett; 2018 Apr; 419():128-138. PubMed ID: 29353077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer.
    Farooqi AA; Fuentes-Mattei E; Fayyaz S; Raj P; Goblirsch M; Poltronieri P; Calin GA
    Semin Cancer Biol; 2019 Oct; 58():47-55. PubMed ID: 30742906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the Relationship between Fusion Genes and MicroRNAs in Cancer.
    Panicker S; Chengizkhan G; Gor R; Ramachandran I; Ramalingam S
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of miRNA-gene regulatory network with clinical significance in human cancers.
    Cui X; Liu Y; Sun W; Ding J; Bo X; Wang H
    Sci China Life Sci; 2020 Aug; 63(8):1201-1212. PubMed ID: 32170623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.
    Lee E; Ito K; Zhao Y; Schadt EE; Irie HY; Zhu J
    Bioinformatics; 2016 Jan; 32(1):96-105. PubMed ID: 26358730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide epigenetic regulation of miRNAs in cancer.
    Baer C; Claus R; Plass C
    Cancer Res; 2013 Jan; 73(2):473-7. PubMed ID: 23316035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA: A signature for cancer progression.
    Hussen BM; Hidayat HJ; Salihi A; Sabir DK; Taheri M; Ghafouri-Fard S
    Biomed Pharmacother; 2021 Jun; 138():111528. PubMed ID: 33770669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial Cancer.
    Wu X; Han Y; Liu F; Ruan L
    J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744.
    Friedrich M; Vaxevanis CK; Biehl K; Mueller A; Seliger B
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32571994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of microRNA deregulation in human cancer.
    Deng S; Calin GA; Croce CM; Coukos G; Zhang L
    Cell Cycle; 2008 Sep; 7(17):2643-6. PubMed ID: 18719391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma.
    Creighton CJ; Hernandez-Herrera A; Jacobsen A; Levine DA; Mankoo P; Schultz N; Du Y; Zhang Y; Larsson E; Sheridan R; Xiao W; Spellman PT; Getz G; Wheeler DA; Perou CM; Gibbs RA; Sander C; Hayes DN; Gunaratne PH;
    PLoS One; 2012; 7(3):e34546. PubMed ID: 22479643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping genetic variability in mature miRNAs and miRNA binding sites in prostate cancer.
    Lee B; Li JL; Marchica J; Mercola M; Patel V; Perera RJ
    J Hum Genet; 2021 Nov; 66(11):1127-1137. PubMed ID: 34099864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation.
    Valeri N; Vannini I; Fanini F; Calore F; Adair B; Fabbri M
    Mamm Genome; 2009; 20(9-10):573-80. PubMed ID: 19697081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of key differentially expressed MicroRNAs in cancer patients through pan-cancer analysis.
    Hu Y; Dingerdissen H; Gupta S; Kahsay R; Shanker V; Wan Q; Yan C; Mazumder R
    Comput Biol Med; 2018 Dec; 103():183-197. PubMed ID: 30384176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.